GLORIA

GEOMAR Library Ocean Research Information Access

X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    A Prospective Study on the Effectiveness of Arsenic Trioxide (ATO) in Remission Induction of Acute Promyelocytic Leukemia (APL)
    Bangladesh Academy of Sciences ; 2015
    In:  Chattagram Maa-O-Shishu Hospital Medical College Journal Vol. 14, No. 2 ( 2015-11-16), p. 5-10
    Details
    In: Chattagram Maa-O-Shishu Hospital Medical College Journal, Bangladesh Academy of Sciences, Vol. 14, No. 2 ( 2015-11-16), p. 5-10
    Abstract: Background: Arsenic Trioxide (ATO) as a single agent, has proven efficacy in inducing molecular remission in patients with Acute Promyelocytic Leukemia (APL). It is commonly used to treat relapsed APL. But there is Limited study on ATO in the management of newly diagnosed cases of APL. The concerned study was done to evaluate the effectiveness and outcome of ATO in remission induction of new cases of APL in the context of a limited resource hospital in Bangladesh.Methods: From March 2008 to March 2010, 20 patients with Promyelocytic Leukemia (PML) / Retinoic Acid Receptor ? (RAR ?) + newly diagnosed APL were enrolled. All patients were treated with a regimen of single-agent arsenic trioxide till remission at our center. After remission the regimen was administered on outpatient basis.Results: Overall 15 (75%) patients achieved complete hematological remission. 12 (80%) patients achieved molecular remission after induction phase and 3 (20%) after completion of consolidation phase. At a median follow up of 36 months (Range 25 -44 months), Disease Free Survival (DFS) and Overall Survival (OS) 86.6% and 85.3% respectively. Relatively young patients with long form of t (15;17) had shown good response with this response. However, the response is slower than All Trans Retinoic Acid (ATRA). Patients presenting with high White Blood Cell (WBC) count, low platelet count, variable form of t (15;17) are found to respond poorly. The toxicity profile, in the majority, was mild and reversible. Treatment cost was also reduced than that of conventional regimen.Conclusion: Single-agent arsenic trioxide as used in this study in the management of newly diagnosed cases of APL is safe, cost beneficent and is associated with durable responses. But additional interventions as combining ATRA with ATO would probably required in high risk cases.Chatt Maa Shi Hosp Med Coll J; Vol.14 (2); Jul 2015; Page 5-10
    Type of Medium: Online Resource
    ISSN: 2306-4919 , 2305-7890
    URL: Article
    DOI: 10.3329/cmoshmcj.v14i2.25709
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2015
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 2
    Online Resource
    Online Resource
    Prevalence of Multidrug-Resistant, Extensively Drug-Resistantand Pandrug-Resistant Uropathogens Isolated From UrinaryTract Infection Cases in Dhaka, Bangladesh
    Maad Rayan Publishing Company ; 2019
    In:  Avicenna Journal of Clinical Microbiology and Infection Vol. 6, No. 2 ( 2019-05-31), p. 44-48
    Details
    In: Avicenna Journal of Clinical Microbiology and Infection, Maad Rayan Publishing Company, Vol. 6, No. 2 ( 2019-05-31), p. 44-48
    Type of Medium: Online Resource
    ISSN: 2383-0298 , 2383-0301
    URL: Article
    DOI: 10.34172/ajcmi.2019.09
    Language: English
    Publisher: Maad Rayan Publishing Company
    Publication Date: 2019
    detail.hit.zdb_id: 2885424-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 3
    Online Resource
    Online Resource
    Clinical Profile, Haematological Changes and Outcomes of Dengue Patients in Dengue Outbreak-2019 in Jashore, Bangladesh- An Observational Study
    Bangladesh Academy of Sciences ; 2021
    In:  Journal of Medicine Vol. 22, No. 1 ( 2021-01-14), p. 33-40
    Details
    In: Journal of Medicine, Bangladesh Academy of Sciences, Vol. 22, No. 1 ( 2021-01-14), p. 33-40
    Abstract: Background: Bangladesh is an endemic zone for re-emerging dengue viral infection since 2000. For the last few years, dengue viral outbreak occurs in the rainy season mostly in Dhaka city and seldom sporadic case finds beyond the Dhaka city of Bangladesh. But this outbreak expands also outside the Dhaka city of Bangladesh in 2019. Therefore, with scarcity of data regarding this field in the peripheral part of Bangladesh, we have designed this study among dengue infected patients in Jashore, Bangladesh. Objectives: This observational study aims to assess the clinical presentations, laboratory findings especially hematological changes and outcomes of patients with dengue viral infection at Jashore district in dengue outbreak-2019 in Bangladesh. Methodology: This was an observational study, carried out from 25thApril 2019 to 5thSeptember 2019 during dengue outbreak season in Jashore, Bangladesh. Patients were selected from outpatient department and indoor of a local private hospital in Jashore, Bangladesh who had given informed written consent to participate in our study. Result: Total eligible 77 patients were included in this study. Out of which 70 patients (90.9%) were dengue NS1 antigen Positive on Immunochromatography (ICT) and the rest were anti-dengue IgM antibody positive on ICT method. Around 74 (96.1%) patients had fever as the most common feature in dengue infection. Eighty-seven percentages (87%) of patients had history of headache. Other striking complaints were body ache (66.2%), back pain (51.9%), nausea (55.8%), vomiting (31.2%), anorexia (27.3%), arthralgia (29.9%) and retro-orbital pain (26.0%). Sore throat being a common feature in flu-like illness also found in 18.2% cases. Mean total count of whole blood count (WBC) falls on day 5 (5.76 X 109/L) and then gradually increased. Mean platelet count of study patient was normal throughout the course of the disease process. But, in some cases minimum platelets was found 21 X 109/L at the time of presentation and on day 5 and day 6 which was dropped down to 17 X 109/L. Mean Haematocrit (%) was more or less in a steady state throughout the acute phage of the disease. But, in some cases throughout the hospital stay minimum haematocrit was less than 30% and initially in some cases maximum haematocrit was more than 50% among some dengue infected patients. Total 67 (87%) subjects with dengue viral infection required hospital admission and mean hospital stay was 4 days with a standard deviation (SD) was ±2 days. Blood transfusion was required in only one patient. Around 95% patient was recovered and only 4 cases were referred to the higher centre further better management. Regarding complications, we had found diarrhoea in 9(11.7%) and bleeding disorder in 14.3% patients. Conclusion: In our study, the most common clinical presentations were fever, headache, body-ache, back pain, and gastrointestinal upset. The mean hematological started dropping down from 4th day and gradually improved after 7th day. Some patients developed diarrhea, bleeding disorders and hepatitis as complications during their disease process. We observed a good clinical outcome evident by without having severity and death toll among our study participants. There was very seldom requirement of blood and blood product transfusion in our study. J MEDICINE JAN 2021; 22 (1) : 33-40
    Type of Medium: Online Resource
    ISSN: 2075-5384 , 1997-9797
    URL: Article
    DOI: 10.3329/jom.v22i1.51389
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2021
    detail.hit.zdb_id: 2549281-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 4
    Online Resource
    Online Resource
    Clinical Consequences and Economic Burden Associated with Febrile Neutropenia in Hospitalized Cancer Patients: A Prospective Study
    Bangladesh Academy of Sciences ; 2022
    In:  Journal of Medicine Vol. 23, No. 1 ( 2022-02-03), p. 48-53
    Details
    In: Journal of Medicine, Bangladesh Academy of Sciences, Vol. 23, No. 1 ( 2022-02-03), p. 48-53
    Abstract: Objective: Febrile neutropenia (FN) is viewed as the most decimating oncological crisis particularly inchemotherapy-incited patients. The primary objective of the study was to identify the total directexpenditure of patients during febrile neutropenia with clinical consequences and the secondary aim wasto find out the factors associated with higher cost. Materials and Method: This was a single-centered hospital-based study in the largest and only specializedcancer care centre in Bangladesh in the government sector. This prospective study was done in theinpatients’ department of the National Institute of Cancer Research and Hospital from April 2020 toJanuary 2021. The primary outcome was the out-of-pocket patient payments (adjusted by governmentsubsidy) per FN episode. Univariate analysis and multiple linear regression were conducted to identifythe factors associated with higher costs. Results and Discussions: A total of 101 patients were enrolled in the study. The mean (SD) age was33.49 (±15.79) years. Of the 101 participants, 63.4% were male. Among the patients, 13.9% died during theepisode and 86.1% recovered. Having co-morbidities and COVID-19 were associated with an increasedrisk of death. The mean cost was US$ 999.44 (±499.05) and the mean length of hospital stay was 21.98(±9.3) days. The longer hospital stay was significantly associated with higher costs. Conclusion: This study will help to ascertain the hospital cost and clinical outcome of FN whichultimately can help in policymaking strategy. J MEDICINE 2022; 23: 48-53
    Type of Medium: Online Resource
    ISSN: 2075-5384 , 1997-9797
    URL: Article
    DOI: 10.3329/jom.v23i1.57937
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2022
    detail.hit.zdb_id: 2549281-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 5
    Online Resource
    Online Resource
    Symptom Burden of Patients with Haematological Malignancy
    Bangladesh Academy of Sciences ; 2021
    In:  Bangladesh Medical Research Council Bulletin Vol. 46, No. 3 ( 2021-03-03), p. 196-203
    Details
    In: Bangladesh Medical Research Council Bulletin, Bangladesh Academy of Sciences, Vol. 46, No. 3 ( 2021-03-03), p. 196-203
    Abstract: Background: Haematological malignancy and its treatment produce multiple symptoms that significantly distress patients and impair function. Symptoms caused by treatment may delay treatment or lead to premature treatment termination and residual treatment-related symptoms often complicate post treatment rehabilitation. When treatment is no longer possible, symptom control becomes the focus of cancer care. Objectives: The study was aimed to determine the symptom burden of the haematological malignancy patients. Methods: A cross sectional study was conducted from July 2015 to June 2016 among the haematological malignancy patients. A total of 316 haematological malignancy adult (age ≥18 years) patients were purposively selected from haematology department of two tertiary level of hospitals in Dhaka city. Face to face interviews were taken from the diagnosed haematological malignancy patients admitted in the hospital and attending outdoor using questionnaire based on symptom distress scale (SDS). Results: Mean age was 39 years and most of the patients suffering from Acute Leukemia 162(51.3%). Mean monthly family income was around 22235 taka and 120(37.9%) patients were unemployed. Patients with haematological malignancy had a considerable physical and psychological symptom burden which ranged from 94.3% for fatigue to 8.5% for difficulty in concentration. Physical symptoms such as fatigue 127 (40.2%), change in appetite 86 (27.2%), pain1 81 (25.6%), insomnia44 (13.9%) caused severedistress and psychological symptoms include change in appearance 37 (11.7%) and outlook 33 (10.4%) were sever distressing. Significant association (p 〈 0.001) was to be found between occupation and symptom distress where 82 (68.4%) unemployed and 51 (66.3%) housewife had moderate/sever symptom distress. Respondents who managed their treatment expenditure by loan and asset sell 11 (84.6%) had significant(p=0.004) moderate/sever distress. Patients having less than one month of diagnosis 47(72.3%) and admitted in inpatient 114 (66.6%) had significant higher moderate/sever symptom distress(p=0.03) and (p 〈 0.001) respectively. Conclusion: Patients with haematological malignancy were likely to have multiple symptoms and comprehensive symptom assessment was suggested throughout. The introduction of supportiveor palliative care services during times of increased symptom burden may assist haematologists and other careers in the management of their patient’s distress and quality of life. Bangladesh Med Res Counc Bull 2020; 46(3): 196-203
    Type of Medium: Online Resource
    ISSN: 2224-7238 , 0377-9238
    URL: Article
    DOI: 10.3329/bmrcb.v46i3.52255
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2021
    detail.hit.zdb_id: 2491184-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 6
    Online Resource
    Online Resource
    Immunophenotypic Characterisation Along with Aberrant Expression of CD markers in Morphologically Diagnosed Cases of Acute Myeloid Leukemia
    Bangladesh Academy of Sciences ; 2022
    In:  Journal of Medicine Vol. 23, No. 2 ( 2022-07-24), p. 106-111
    Details
    In: Journal of Medicine, Bangladesh Academy of Sciences, Vol. 23, No. 2 ( 2022-07-24), p. 106-111
    Abstract: Immunophenotyping of leukemia cells is useful for detecting leukemia cell line, determining maturation stage and identifying aberrant antigens which act for individual treatment monitoring and detection of residual disease. A total of 104 newly diagnosed cases of acute myeloid leukemia were identified at hematology department in National Institute of Cancer Research and Hospital from January 2020 to December 2021.We detect Immunophenotypic pattern in newly diagnosed cases of acute myeloid leukemia. We also determine the frequency and pattern of aberrant expression of CD markers in acute myeloid leukemia patients. Mean age of patients was 35 years (SD±16 years) with male to female ratio was 1.53:1. Most frequent morphologic subtype was AMLM2 constituting 33.6% of all AML cases. Lineage specific markers HLADR, CD13, CD33, MPO, CD117 and CD34 were expressed in 80%, 89%, 95%, 77%, 74% and 62% cases of all AML cases respectively. Among 104 AML patient, aberrant CD expression was observed in 36% cases. The most frequently observed aberrant markers were CD7 and CD19 lymphoid markers, that were expressed in 15.38% and 14.42% cases respectively. Less frequent aberrant cCD3, CD10, CD5 and cCD79a antigens were expressed in 2.88%, 1.92%, 0.96% and 0.96% cases respectively. Immunophenotyping is essential in diagnosis and sub-classification of AML and expression of aberrant CD antigens is common in acute myeloid leukemia. These findings suggest the necessity for a more extensive study to evaluate the prognostic significance of aberrant CD marker expression in AML and to improve the accuracy of diagnosis and classification of AML. J MEDICINE 2022; 23: 106-111
    Type of Medium: Online Resource
    ISSN: 2075-5384 , 1997-9797
    URL: Article
    DOI: 10.3329/jom.v23i2.60626
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2022
    detail.hit.zdb_id: 2549281-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 7
    Online Resource
    Online Resource
    Symptomatic Outcome of CTDa In Multiple Myeloma Patients
    Bangladesh Academy of Sciences ; 2020
    In:  KYAMC Journal Vol. 11, No. 3 ( 2020-10-21), p. 124-128
    Details
    In: KYAMC Journal, Bangladesh Academy of Sciences, Vol. 11, No. 3 ( 2020-10-21), p. 124-128
    Abstract: Background: Multiple Myeloma (MM) represents approximately 15% of all hematological malignancies. Despite the use of high-dose chemotherapy followed by stem cell rescue MM remains incurable at present. The goal is to control the disease as much as possible, providing the best quality of life to patients for the longest duration. Currently, CTDa (attenuated Cyclophosphamide, Thalidomide, Dexamethasone) is the best option of treatment as it is cost-effective, with no need for hospitalization with a good response. Objective: To find out the symptomatic responses and toxicities of CTDa in Multiple Myeloma patients. Materials and Methods: 25 patients of newly diagnosed MM patients were treated in the Haematology Department, Bangabandhu Sheikh Mujib Medical University (BSMMU) from July 2016 to July 2017. The mean age of the patients was 54 years, Male female ratio was 1.5:1 and most of the patients were farmers. After induction of 4 to 6 cycles of CTDa all patients were followed up at 6th and 12th weeks. At follow up we evaluated improvement of weakness, bone pain, Hb%, ESR, monoclonal protein, ß2microglobulin, bone marrow plasma cells and serum calcium and albumin level. Adverse effects, such as peripheral neuropathy, thromboembolic events, hyperglycemia, constipation, rash, and somnolence were also assessed. Results: Among 25 patients, complete response achieved only 13 patients (52%), where 20% and 16% of patients belonged to partial or no response respectively. The death occurred in 2 cases (12%). Conclusion: CTDa is a gentle approach to treat an especially frail group of patients, since virtually all patients ultimately relapse. KYAMC Journal Vol. 11, No.-3, October 2020, Page 124-128
    Type of Medium: Online Resource
    ISSN: 2308-2860 , 2308-2720
    URL: Article
    DOI: 10.3329/kyamcj.v11i3.49868
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 8
    Online Resource
    Online Resource
    Clinicopathological Correlation with Outcome of Diffuse Large B Cell Lymphoma: Experience in a Specialized Cancer Care Centre in Bangladesh
    Bangladesh Academy of Sciences ; 2021
    In:  Journal of Medicine Vol. 22, No. 1 ( 2021-01-14), p. 3-6
    Details
    In: Journal of Medicine, Bangladesh Academy of Sciences, Vol. 22, No. 1 ( 2021-01-14), p. 3-6
    Abstract: Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in the world, and accounts for 30%–40% of all adult NHLs. It is clinically, morphologically and genetically a heterogeneous group of tumors composed of large B cells. This study aimed to determine the clinical features, treatment options, the response rate in a specialized cancer care centre. Methods: This retrospective study included all DLBCL patients registered in the department of Haematology of National Institute of Cancer Research and Hospital (NICR & H), Bangladesh between July 2016 to June 2019. Results: A total of 151cases were included in this study. The mean age was 47 years with a standard deviation (SD) of 15 years. Males (66.2%) were more in the occurrence of DLBCL. We divided the cases into three different entities of DLBCL and non-germinal centre B (non-GCB) variety was the prevalent (46.4%) one. Several types of first-line chemotherapy were used in management and the overall response rate (ORR) was 76.6% and 9.2% of death. The response was found to be significant with B symptoms, stage, and international prognostic index (IPI) score. But no significant difference was observed in outcome among different types of DLBCL after treatment. Conclusion: This retrospective study will help to ascertain the co relation of DLBCL outcome with clinicopathological profile. (edited) J MEDICINE JAN 2021; 22 (1) : 3-6
    Type of Medium: Online Resource
    ISSN: 2075-5384 , 1997-9797
    URL: Article
    DOI: 10.3329/jom.v22i1.51383
    Language: Unknown
    Publisher: Bangladesh Academy of Sciences
    Publication Date: 2021
    detail.hit.zdb_id: 2549281-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 9
    Online Resource
    Online Resource
    Platelet Count Increment after Transfusion of Fresh and Stored Platelet Concentrates in Children with Acute Lymphoblastic Leukaemia
    Haematology Society of Bangladesh ; 2020
    In:  Haematology Journal of Bangladesh Vol. 2, No. 01 ( 2020-05-13), p. 8-13
    Details
    In: Haematology Journal of Bangladesh, Haematology Society of Bangladesh, Vol. 2, No. 01 ( 2020-05-13), p. 8-13
    Abstract: Background: Therapeutic platelet transfusion is necessary to prevent bleeding due to thrombocytopenia in childhood acute lymphoblastic leukaemia (ALL). Platelet concentrates may be transfused as fresh platelet concentrate immediately or with five days of storage after collection Objectives: To compare the platelet count increment between fresh and stored platelet concentrate transfusion in children with acute lymphoblastic leukaemia.  Methodology: This observational study was carried out in the Department of Clinical Pathology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, in collaboration with the Department of Transfusion Medicine and Paediatric Haemato-Oncology, BSMMU, Dhaka. Seventy-two children diagnosed as acute lymphoblastic leukaemia were included in this study. ABO identical whole-blood derived platelet-rich-plasma platelet concentrates (PRP-PCs) were transfused within 24 hours of preparation or 1-5 days of storage. Effectiveness of platelet transfusion was carried out by measuring platelet count prior to transfusion, subsequently 1 hour and 24 hours of transfusion. Result: Post transfusion platelet count at 1 hour and 24 hours with fresh platelet concentrates (FPC) and stored platelet concentrates (SPC) were not statistically significant. Post transfusion platelet increment at 1 hour and 24 hours were also similar in both FPC and SPC. Corrected count increment (CCI) at 1 hour in FPC and SPC were 20.5±10.1 and 18.6 ±6.5 respectively and was statistically not significant (P: 0.168). CCI at 24 hours were 15.5±9.1 and 13±5.8 which were also statistically not significant. Percentage platelet recovery at 1 hour and 24 hours in both FPC and SPC were statistically not significant. But these values in SPC were consistently lower than that of FPC. All the values of FPC and SPC were well apart from the lower limit of CCI and percentage platelet recovery (PPR). It was also observed that 85.1% satisfactory platelet transfusion was achieved with FPC and rest of 14.9% was platelet refractory cases. In 79.5% cases satisfactory platelet transfusion were achieved with SPC and refractory cases were 20.5 %.  Conclusion: One to five day’s stored PRP-PCs are as effective as fresh PRP-PCs to achieve satisfactory platelet increment.
    Type of Medium: Online Resource
    ISSN: 2707-1405 , 2523-1219
    URL: Article
    DOI: 10.37545/haematoljbd201811
    Language: Unknown
    Publisher: Haematology Society of Bangladesh
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 10
    Online Resource
    Online Resource
    Bone Marrow Involvement in Non-Hodgkin Lymphoma at Diagnosis
    Haematology Society of Bangladesh ; 2020
    In:  Haematology Journal of Bangladesh Vol. 3, No. 01 ( 2020-05-24), p. 3-7
    Details
    In: Haematology Journal of Bangladesh, Haematology Society of Bangladesh, Vol. 3, No. 01 ( 2020-05-24), p. 3-7
    Abstract: Background: In lymphoma, bone marrow infiltration of lymphocytes is a vital information of staging can be done primarily by observer dependent bone marrow study or trephine biopsy. Objective: Aim of this study is to observe the frequency of bone marrow involvement in Non-Hodgkin lymphoma at the time of diagnosis by trephine biopsy and to determine importance of bone marrow trephine biopsy over bone marrow aspiration for staging of Non-Hodgkin lymphoma. Methodology: This was a prospective observational study conducted between January 2014 to July 2014 in department of Haematology, Bangabandhu Shaikh Mujib Medical University (BSMMU) including 30 newly diagnosed patients of Non-Hodgkin’s Lymphoma (NHL) between 15 to 75 years of both sex in non-probability purposive sampling manner confirmed by histopathology of biopsy of lymph node or extra nodal mass. Any secondary disease associated NHL and if there were history of prior chemotherapy was excluded from this study. Detailed clinical history, physical examinations & relevant investigations were recorded in data sheet. After taking written informed consent, these patient’s bone marrow by aspiration and trephine biopsy and peripheral blood sample were sent for study. Results: Comparing bone marrow aspirates (BMA) with bone marrow biopsy (BMB) report revealed that 17 cases were BMB positive among them 12 (70.5%) cases were BMA positive and 5 (29.5%) cases were BMA negative. 13 cases were BMB negative among them 1 (7.7%) case was BMA positive and 12 (92.3%) cases were BMA negative. Statistical analysis revealed significant value ( 〈 0.001) that is, there is significant difference observed between two methods to see bone marrow lymphoid infiltration. But in agreement between these two methods we found Kappa (k) value 0.61 indicates a Good agreement between these two tests; that is, we can perform any of these tests to see bone marrow lymphocytes infiltration. Conclusion: Bone marrow study and trephine biopsy can be employed to see lymphoid infiltration in lymphomas with a good agreement; though trephine biopsy has its superiority.
    Type of Medium: Online Resource
    ISSN: 2707-1405 , 2523-1219
    URL: Article
    DOI: 10.37545/haematoljbd201926
    Language: Unknown
    Publisher: Haematology Society of Bangladesh
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...